Zevra Therapeutics Long Term Deferred Charges (Quarterly) Analysis

Zevra Therapeutics, Inc. (ZVRA)

8.62 +0.14 (+1.65%) USD | NASDAQ | Jan 08, 16:00

8.69 +0.07 (+0.81%) After-Hours: 20:00

View Long Term Deferred Charges (Quarterly) for ZVRA.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Charges (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Charges (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Charges (Quarterly) Benchmarks

Start Trial

XOMA Royalty Corp.	--
Verastem, Inc.	--
ADMA Biologics, Inc.	--
Akebia Therapeutics, Inc.	--
NovaBay Pharmaceuticals, Inc.	--